Companies / Colgate Palmolive Co / Activity
Activity — Colgate Palmolive Co
51 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Sutula Stanley J III Executive | Sell | Common Stock | $9.22M | -98K -63.89% | 55,310 <0.01% of shares | medium |
| Feb 4, 2026 | Sutula Stanley J III Executive | Exercise | Common Stock | $8.00M | +98K +176.90% | 153,153 0.02% of shares | low |
| Feb 23, 2026 | Wallace Noel R. CEO | Other | Common Stock | $6.63M | -68K -15.87% | 361,921 0.05% of shares | low |
| Feb 4, 2026 | Wallace Noel R. CEO | Sell | Common Stock | $4.28M | -46K -13.45% | 293,188 0.04% of shares | medium |
| Feb 11, 2026 | Tsourapas Panagiotis Executive | Sell | Common Stock | $3.31M | -35K -77.07% | 10,415 <0.01% of shares | medium |
| Feb 11, 2026 | Tsourapas Panagiotis Executive | Exercise | Common Stock | $2.67M | +35K +336.05% | 45,415 <0.01% of shares | low |
| Feb 4, 2026 | Daniels Jennifer Executive | Sell | Common Stock | $2.08M | -22K -22.36% | 76,406 <0.01% of shares | medium |
| Feb 10, 2026 | Hazlin John Executive | Sell | Common Stock | $1.98M | -21K -54.33% | 17,645 <0.01% of shares | medium |
| Feb 23, 2026 | Sutula Stanley J III Executive | Other | Common Stock | $1.92M | -20K -20.99% | 74,320 <0.01% of shares | low |
| Feb 10, 2026 | Hazlin John Executive | Exercise | Common Stock | $1.60M | +21K +118.95% | 38,634 <0.01% of shares | low |
| Feb 4, 2026 | Daniels Jennifer Executive | Exercise | Common Stock | $1.59M | +22K +28.79% | 98,406 0.01% of shares | low |
| Feb 5, 2026 | Massey Sally Executive | Sell | Common Stock | $1.51M | -16K -53.55% | 13,751 <0.01% of shares | medium |
| Feb 12, 2026 | Tsourapas Panagiotis Executive | Sell | Common Stock | $1.47M | -15K -59.02% | 10,415 <0.01% of shares | medium |
| Feb 23, 2026 | Tsourapas Panagiotis Executive | Other | Common Stock | $1.27M | -13K -37.69% | 21,629 <0.01% of shares | low |
| Feb 5, 2026 | Massey Sally Executive | Exercise | Common Stock | $1.21M | +16K +115.27% | 29,602 <0.01% of shares | low |
| Feb 6, 2026 | Malcolm Gregory Executive | Sell | Common Stock | $1.21M | -13K -51.76% | 11,879 <0.01% of shares | medium |
| Feb 23, 2026 | Daniels Jennifer Executive | Other | Common Stock | $1.20M | -12K -12.09% | 89,844 0.01% of shares | low |
| Feb 12, 2026 | Tsourapas Panagiotis Executive | Exercise | Common Stock | $1.15M | +15K +144.02% | 25,415 <0.01% of shares | low |
| Feb 6, 2026 | Malcolm Gregory Executive | Exercise | Common Stock | $974.0K | +13K +107.31% | 24,626 <0.01% of shares | low |
| Feb 23, 2026 | Massey Sally Executive | Other | Common Stock | $796.8K | -8K -26.83% | 22,384 <0.01% of shares | low |
| Feb 23, 2026 | Hazlin John Executive | Other | Common Stock | $594.0K | -6K -20.03% | 24,422 <0.01% of shares | low |
| Feb 23, 2026 | Malcolm Gregory Executive | Other | Common Stock | $219.4K | -2K -12.45% | 15,898 <0.01% of shares | low |
| Jan 2, 2026 | Norrington Lorrie M Director | Grant | Common Stock | $26.2K | +333 +0.85% | 39,648 <0.01% of shares | low |
| Apr 1, 2026 | Norrington Lorrie M Director | Grant | Common Stock | $26.2K | +294 +0.74% | 40,160 <0.01% of shares | low |
| Apr 1, 2026 | Bilbrey John P Director | Grant | Common Stock | $23.7K | +266 +0.71% | 37,665 <0.01% of shares | low |
| Jan 2, 2026 | Bilbrey John P Director | Grant | Common Stock | $23.7K | +301 +0.82% | 37,195 <0.01% of shares | low |
| Jan 2, 2026 | Newman Brian Director | Grant | Common Stock | $18.7K | +238 +4.69% | 5,313 <0.01% of shares | low |
| May 11, 2026 | Bilbrey John P Director | Grant | Common Stock | $0 | +2K +5.50% | 39,820 <0.01% of shares | low |
| May 11, 2026 | Harris C Martin Director | Grant | Common Stock | $0 | +2K +6.78% | 24,517 <0.01% of shares | low |
| May 11, 2026 | Hundmejean Martina Director | Grant | Common Stock | $0 | +2K +14.68% | 16,206 <0.01% of shares | low |
| May 11, 2026 | Cahill John T Director | Grant | Common Stock | $0 | +2K +7.94% | 28,216 <0.01% of shares | low |
| May 11, 2026 | Norrington Lorrie M Director | Grant | Common Stock | $0 | +2K +5.16% | 42,312 <0.01% of shares | low |
| Feb 23, 2026 | Hazlin John Executive | Grant | Common Stock | $0 | +13K +72.19% | 30,539 <0.01% of shares | low |
| Feb 23, 2026 | Malcolm Gregory Executive | Grant | Common Stock | $0 | +6K +52.72% | 18,158 <0.01% of shares | low |
| Feb 23, 2026 | Massey Sally Executive | Grant | Common Stock | $0 | +17K +121.91% | 30,590 <0.01% of shares | low |
| Feb 23, 2026 | Sutula Stanley J III Executive | Grant | Common Stock | $0 | +39K +69.83% | 94,066 0.01% of shares | low |
| Feb 23, 2026 | Tsourapas Panagiotis Executive | Grant | Common Stock | $0 | +26K +287.04% | 34,710 <0.01% of shares | low |
| Feb 23, 2026 | Wallace Noel R. CEO | Grant | Common Stock | $0 | +137K +46.59% | 430,173 0.05% of shares | low |
| Feb 23, 2026 | Daniels Jennifer Executive | Grant | Common Stock | $0 | +26K +33.67% | 102,195 0.01% of shares | low |
| May 11, 2026 | Bilbrey John P Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,424 <0.01% of shares | low |
| May 11, 2026 | Harris C Martin Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,424 <0.01% of shares | low |
| May 11, 2026 | Hundmejean Martina Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,424 <0.01% of shares | low |
| May 11, 2026 | Cahill John T Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,424 <0.01% of shares | low |
| May 11, 2026 | Norrington Lorrie M Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,424 <0.01% of shares | low |
| Feb 10, 2026 | Hazlin John Executive | Exercise | Stock Option (Right to Buy) | — | -21K -100.00% | 0 0.00% of shares | low |
| Feb 6, 2026 | Malcolm Gregory Executive | Exercise | Stock Option (Right to Buy) | — | -13K -100.00% | 0 0.00% of shares | low |
| Feb 5, 2026 | Massey Sally Executive | Exercise | Stock Option (Right to Buy) | — | -16K -100.00% | 0 0.00% of shares | low |
| Feb 4, 2026 | Sutula Stanley J III Executive | Exercise | Stock Option (Right to Buy) | — | -98K -100.00% | 0 0.00% of shares | low |
| Feb 12, 2026 | Tsourapas Panagiotis Executive | Exercise | Stock Option (Right to Buy) | — | -15K -42.93% | 19,938 <0.01% of shares | low |
| Feb 11, 2026 | Tsourapas Panagiotis Executive | Exercise | Stock Option (Right to Buy) | — | -35K -50.04% | 34,938 <0.01% of shares | low |